Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMED2 pseudogene 1 (TMED2P1) is a pseudogene; that is, a DNA sequence similar to the functional TMED2 gene but lacking the ability to encode a functional protein. Pseudogenes are often considered non-functional remnants of evolution and do not produce active proteins or serve as therapeutic targets. In contrast, the protein-coding TMED2 gene encodes the transmembrane p24 trafficking protein 2, which is involved in vesicular protein trafficking and has been researched as a potential cancer biomarker and drug target[1][2][3][4]. TMED2P1, however, does not have such roles or significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMED2 pseudogene 1 (TMED2P1).